Study of the Sentire Robotic Surgical System for Major Gastrointestinal and Urologic Surgeries with Lower Costs and Minimally Invasive Techniques

What this Trial Is About

Robotic-assisted surgery has been used successfully for over 20 years, mainly relying on one major system that results in high costs. Researchers from The Chinese University of Hong Kong CUHK have developed a new robotic surgical system called the Sentire Robotic Surgical System, designed to offer similar surgical outcomes at a significantly lower cost. An initial pilot study with 55 patients showed promising success and safety in colorectal, upper gastrointestinal, and urologic surgeries, leading to this further study to evaluate its use in major gastrointestinal and urologic surgeries with expanded indications. This study involves robotic surgery using the Sentire Surgical System for various minimally invasive procedures treating conditions like colorectal carcinoma, prostate cancer, bladder and kidney cancers, gastric and esophageal tumors, and others. The system aims to reduce trauma and costs compared to existing robotic platforms. The research will assess the surgical outcomes and safety profile of this technology in these procedures. Participants will undergo robotic surgeries with the Sentire system and be monitored for up to 12 months. Researchers will evaluate conversion rates to open surgery, perioperative complications, operative time, blood loss, pain levels, analgesic use, hospital stay length, surgical margin status, lymph node removal, and post-surgery functions including anal continence, male sexual function, and urinary function. These assessments will help determine the systems effectiveness and safety during and after surgery.

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery